|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||||
  Headache: The Journal of Head and Face PainVolume 32 Issue 2, Pages 95 - 97 Published Online: 19 May 2005 © 2010 American Headache Society Published on behalf of the American Headache Society
Abstract | Full Text: PDF (Size: 65K) | Related Articles | Citation Tracking  Abortive Migraine Therapy With Oral Naproxen Sodium Plus Metoclopramide Plus Ergotamine Tartrate With Caffeine Clinical Professor of Medicine, Department of Medicine and Section of Infectious Disease, University of Oklahoma Health Sciences Center and Mercy Health Center. Copyright © 1992 American Headache Society (formerly the American Association for the Study of Headache) KEYWORDS naproxen sodium • metoclopramide • ergotamine tartrate • and caffeine, abortive therapy, migraine ABSTRACTSYNOPSIS The oral tablet combination, (550 mgs. of naproxen sodium plus 10 mgs. of metoclopramide plus 1 mg. of ergotamine tartrate plus 100 mgs. of caffeine), was retrospectively studied in 63 patients who used it to abort migraine headaches. On the average, 84% of the headaches were totally aborted; minor side effects occurred in 40% of the patients, and 87% of the patients considered the combination superior to all prior treatments. Accepted for Publication: September 10, 1991. | 
|
